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The purpose of this study was to conduct an 8 week endurance training program with
and without (−)−epicatechin treatment and to determine whether there is a possible
cumulative effect on protein markers of angiogenesis and mitochondrial biogenesis. Thirty-
four 14-month old male mice (C57BL/6N) were randomized into four groups: control (C);
(−)−epicatechin only ((−)−Epi); control with endurance training (CE); and (−)−epicatechin
with endurance training ((−)−Epi-Ex). Mice in the training groups performed treadmill
exercise for 8 weeks (5× /week for 60 min/session), whereas mice in the (−)−epicatechin
group received 1.0 mg/kg of body mass twice daily during the training period. At
8 weeks, distance ran on the treadmill increased by 46, 69, and 84% in the (−)−Epi,
CE, and (−)−Epi-Ex groups, respectively compared to the control group (p < 0.001 for
all comparisons). Furthermore, the (−)−Epi-Ex group had significantly higher exercise
capacity than the (−)−Epi and CE group. For angiogenic regulators, the (−)−Epi-Ex group
had significantly higher VEGF-R2 protein expression with a concomitant reduction in TSP-1
protein expression than the exercise group. Interestingly, FoxO1 protein expression was
significantly reduced for all three experimental groups compared to the control group.
Protein markers such as PGC-1β and TFAM were significantly higher in the (−)−Epi-Ex
group compared to the three other groups. These findings suggest that (−)−epicatechin
treatment combined with 8 weeks of endurance training provide a cumulative effect
on a number of angiogenic and mitochondrial signaling which functionally translates to
enhanced exercise tolerance.
Keywords: exercise tolerance, muscle, skeletal, fatigue, mouse model, mitochondrial proteins
INTRODUCTION
One of the foundations of exercise physiology is that endurance
training increases the delivery and utilization of oxygen to the
working muscle (Wagner, 1996; Saltin and Calbet, 2006). The
delivery of oxygen from the blood to the muscle is facilitated by
capillaries (Wagner, 1996). Studies have suggested that capillary
growth results from a balance between pro-angiogenic factors
such as vascular endothelial growth factor (VEGF-A; Olfert et al.,
2009; Hüttemann et al., 2012; Lee et al., 2012; Malek et al., 2013)
Abbreviations: ADAMTS-1: disintegrin and metalloproteinase with throm-
bospondin motifs 1; ANOVA: analysis of variance; C: control (C); CcO:
cytochrome c oxidase; CE: control with endurance training; (−)−Epi:
(−)−epicatechin only; (−)−Epi-Ex: (−)−epicatechin with endurance train-
ing; FoxO1: forkhead box O1; PGC-1: peroxisome proliferator-activated
receptor gamma coactivator 1; VEGF-A: vascular endothelial growth factor;
VEGF-R2: VEGF receptor 2; TSP-1: thrombospondin-1.
and anti-angiogenic factors such as thrombospondin-1 (TSP-1;
Audet et al., 2011; Hüttemann et al., 2012; Roudier et al., 2012;
Malek et al., 2013). Recently, Roudier et al. (2013) indicated
that forkhead box O1 (FoxO1) deletion attenuated TSP-1 protein
which improved blood flow in ischemic skeletal muscle of mice.
Once the oxygenated blood is delivered to the muscle it is shuttled
to the mitochondria (Wagner, 1996).
The ultimate goal of oxygen delivery and utilization is energy
production in the mitochondria. This takes place in the electron
transport chain, where cytochrome c oxidase (CcO) accepts elec-
trons from cytochrome c, reduces 90% of cellular oxygen to water,
and pumps protons across the inner mitochondrial membrane
generating the mitochondrial membrane potential, which is used
by ATP synthase to generate ATP from ADP and phosphate
(Hüttemann et al., 2007). It has been suggested that CcO is the
rate-limiting enzyme of the electron transport chain in mammals
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(Villani and Attardi, 1997; Villani et al., 1998; Acin-Perez et al.,
2003; Piccoli et al., 2006; Dalmonte et al., 2009; Pacelli et al.,
2011). Moreover, for robust aerobic energy production mitochon-
drial maintenance and biogenesis are crucial, and studies have
shown that PGC-1 (peroxisome proliferator-activated receptor
gamma coactivator 1) may play a role in this process (Pogozelski
et al., 2009; Matiello et al., 2010; Rowe et al., 2011).
Previously, Nogueira et al. (2011) examined the effects of
15 days of (−)−epicatechin treatment with and without exercise
on hindlimb skeletal muscle capillarity and mitochondrial bio-
genesis of 12 month old male mice. The investigators (Nogueira
et al., 2011) stated, “. . .the intent was not to provide a training
stimulus, but rather to determine if (−)−epicatechin needed a
metabolic stimulus to have an effect, as reported for GW1516
by Narkar et al. (2008, p. 4617).” The investigators reported
increased skeletal muscle capillarity, but did not examine pro-
tein expression of various angiogenic regulators. Nogueira et al.
(2011), however, found increased protein expression for vari-
ous mitochondrial complexes which corresponded to increases
in mitochondrial volume and cristae abundance in the group
receiving (−)−epicatechin compared to the vehicle group inde-
pendent of the exercise intervention. The Nogueira et al. (2011)
study provided initial data regarding the short-term effects of
(−)−epicatechin treatment on skeletal muscle structure and
function. Subsequent studies on (−)−epicatechin have shown
that (−)−epicatechin attenuates detraining effects on skeletal
muscle (Hüttemann et al., 2012) as well as increases angiogenic
and mitochondrial signaling in rats with innate low running
capacity (LCR; Hüttemann et al., 2013). These studies used either
14 (Hüttemann et al., 2012) or 30 days (Hüttemann et al., 2013)
of (−)−epicatechin treatment in the absence of an endurance
training intervention. These findings suggest, therefore, that
(−)−epicatechin may function as a partial exercise mimetic. Nev-
ertheless, a couple of critical questions about (−)−epicatechin
treatment have yet to be answered: “What are the long-term effects
of (−)−epicatechin treatment on skeletal muscle function?;” and
“Does (−)−epicatechin treatment in combination with endurance
training provide a cumulative effect on delivery and utilization of
oxygen in the hindlimb muscles?”
The purpose of this study, therefore, was to conduct an 8 week
endurance training program with and without (−)−epicatechin
treatment and to determine whether there is a possible cumu-
lative effect on protein markers of angiogenesis and mitochon-
drial biogenesis. We hypothesized that animals treated with
(−)−epicatechin would have similar skeletal muscle adaptations
as endurance trained animals. Furthermore, we hypothesized
that the combination of (−)−epicatechin and endurance train-
ing would provide a cumulative effect for both angiogenic and
mitochondrial signaling.
MATERIALS METHODS
ANIMAL APPROVAL AND HOUSING
Mice were 14-month old, male C57BL/6N (N = 34, Harlan
Laboratories, Inc.) at the beginning and 16-month old at the
termination of the study. We selected an older age relative to our
initial study [12 month old; (Nogueira et al., 2011)] because Fra-
zier et al. (2011) reported decreased mitochondrial function and
endurance capacity with age. Animals were placed two per cage
and provided a standard chow diet (Picolab® Laboratory Rodent
Diet 5L0D; LabDiet, St. Louis, MO, USA) without restrictions. In
addition, room temperature was maintained at 21 °C with 12-h
light:dark cycles. All animal care and experimental procedures
were approved by the Wayne State University Institutional Animal
Care and Use Committee.
RESEARCH DESIGN
A between-subjects design was used in which mice were random-
ized into four groups: (1) control (C); (2) (−)−epicatechin only
((−)−Epi); (3) control with endurance training (CE); and (4)
(−)−epicatechin with endurance training ((−)−Epi-Ex). There-
after, all groups performed a maximal treadmill test to exhaustion.
A final maximal treadmill test was performed at 8 weeks.
MAXIMAL TREADMILL TEST
All animals were familiarized with the treadmill the week prior
to the maximal treadmill test. The mice ran on the treadmill
(1055MSD Exer-6M, Columbus, OH, USA) at a slow speed
(≈≈5 m min−1) at 0° incline for approximately 5–10 min. On the
test day, animals began with a warm-up at 4 m min−1 for 2 min
followed by an increase of 2 m min−1 every min thereafter. Testing
of animals and determination of exhaustion was consistent with
our previous rodent model studies (Malek and Olfert, 2009;
Malek et al., 2010, 2013; Nogueira et al., 2011; Hüttemann et al.,
2012; Lee et al., 2012). We used the total distance ran as the
outcome variable for exercise tolerance because Koch and Britton
(2001) as well as Girard et al. (2001) have shown this index to be
the best predictor of endurance capacity.
ENDURANCE TRAINING PROTOCOL FOR 8 WEEKS
For 8 weeks, animals in the CE and (−)−Epi-Ex groups per-
formed treadmill exercise at 60% of the maximum work rate at
5° incline for 60 min 5 times per week (Monday through Friday).
The training sessions were performed between 8:00 and 11:00 am.
Variations of this protocol have shown increased angiogenic and
mitochondrial adaptations in the working muscle (Hüttemann
et al., 2012; Malek et al., 2013). Animals in the control and
(−)−Epi groups were placed on a non-moving treadmill belt
during each session.
(−)−EPICATECHIN TREATMENT
Consistent with our previous work on (−)−epicatechin in mice
(Nogueira et al., 2011; Hüttemann et al., 2012) and rats (Hüt-
temann et al., 2013) animals in the (−)−epicatechin groups
were given a dosage of 1.0 mg/kg of body mass twice a
day [morning (7:00 am) and evening (7:00 pm)]. Animals in
groups 1 and 3 received vehicle (water). In our previous stud-
ies (Nogueira et al., 2011; Hüttemann et al., 2012) animals
were given (−)−epicatechin (dissolved in water) on consecutive
days during the treatment period. Recently, however, Hüttemann
et al. (2013) showed sustained angiogenic and mitochondrial
signaling 15 days after cessation of (−)−epicatechin treatment.
Therefore, in the current study, animals were given either the
vehicle or (−)−epicatechin (Sigma-Aldrich, St. Louis, MO, USA)
using a Monday through Friday schedule for 8 weeks which
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would correspond with the exercise training regimen. Delivery
of (−)−epicatechin and vehicle in the present study was via oral
gavage by experienced personnel. The total volume of oral gavage
per session per animal was≈0.20 ml twice daily.
TISSUE HARVESTING PROCEDURE
All animals were overdosed with sodium pentobarbital
(200 mg/kg, i.p.) 72 h after the final maximal treadmill test.
Thereafter the hindlimb muscles (quadriceps femoris, lateral
gastrocnemius, and plantaris muscles) were harvested. This
approach was taken in order to examine the basal protein
expression in the muscle rather than examining the response
immediately following exercise. The method of sectioning and
storing the muscle was consistent with our previous work (Malek
and Olfert, 2009; Malek et al., 2010, 2013; Nogueira et al., 2011;
Hüttemann et al., 2012, 2013; Lee et al., 2012).
MEASUREMENT OF CAPILLARITY
The Rosenblatt et al. (1987) capillary staining method was used
for the plantaris muscle. Muscle sections were viewed under a
digital microscope (20 × magnification, Leica DMD108, Buffalo
Grove, IL, USA) and randomly selected for animals in each group
corresponding to ≈85% of the entire muscle being analyzed for
each animal. Quantification of capillaries were performed using
the recommended method of Hepple (Hepple, 1997; Hepple and
Mathieu-Costello, 2001) by measuring the following: (1) the
number of capillaries around a fiber (NCAF), (2) the capillary-to-
fiber ratio on an individual-fiber basis (C/Fi), and (3) capillary
density (CD) which was calculated by using the fiber area as
the reference space Capillary-to-fiber perimeter exchange index
(CFPE) was estimated from the capillary-to-fiber surface area
Fiber cross-sectional area (FCSA) and perimeter (FP) was mea-
sured with the image analysis system and commercial software
(SigmaScan Pro v. 5.0, Systat Software, Inc., Point Richmond,
CA, USA). This approach is routinely used in our laboratory
(Hüttemann et al., 2012, 2013; Lee et al., 2012; Malek et al., 2013).
PROTEIN ANALYSIS
The Western blot procedure was consistent with our previous
work and detailed elsewhere (Hüttemann et al., 2012, 2013; Lee
et al., 2012; Malek et al., 2013). Samples were loaded onto 7.5%
(TSP-1, PGC-1α, PGC-1β, and ADAMTS-1) or 12% TGX pre-cast
gels (Bio-Rad, Hercules, CA, USA).
The mouse monoclonal primary antibodies used were
TSP-1 (1:500, sc-59886, Santa Cruz Biotechnology, Inc), CD47
(1:500; 3847-1, Epitomics), PGC-1β (1:100; sc-373771, Santa
Cruz Biotechnology, Inc), α-tubulin (1:2,000, ab11304, Abcam),
ADAMTS1 (1:500; sc-47726, Santa Cruz Biotechnology, Inc), and
GAPDH (1:2,000, ab9484, Abcam). The polyclonal primary anti-
bodies used were VEGF (1:500, sc-507, Santa Cruz Biotechnol-
ogy, Inc), VEGFR2 (1:500; 2479, Cell Signaling), FoxO1 (1:200;
2880, Santa Cruz Biotechnology, Inc), Anti-TFAM (1:1,000;
ab131607, Abcam), and PGC-1α (1:1,000; AB3242, Millipore).
The secondary antibodies used were goat anti-mouse IRDye
(1:30,000) and goat anti-rabbit IRDye (1:30,000) purchased
from Li-Cor Biosciences. Loading control for target proteins
were normalized to α-tubulin or GAPDH. Quantification of
bands were analyzed with the Odyssey software program (Li-Cor
Biosciences).
CITRATE SYNTHASE AND CYTOCHROME c OXIDASE ACTIVITY
Citrate synthase activity was measured in the lateral gastrocne-
mius muscle of animals in each group. The method of Srere
(1969) was used and samples were analyzed with a Beckman
DU 730 spectrophotometer (Beckman, Fullerton, CA, USA) at
412 nm. All samples were tested in triplicate and measured at
37°C as we have done before (Hüttemann et al., 2012; Malek et al.,
2013).
To determine the acute effects of (−)−epicatechin on the
kinetics of cellular respiration independent of the 8 weeks of
(−)−epicatechin treatment and/or the endurance training inter-
vention frozen quadriceps muscles from animals in the control
group were incubated in solution containing 20 µM final concen-
tration of (−)−epicatechin or water (placebo) for 25 min. CcO
specific activity was measured with a micro Clark-type oxygen
electrode in a closed chamber (Oxygraph system, Hansatech,
Norfolk, England) at 25°C. Frozen cells were solubilized in 10 mM
K-HEPES (pH 7.4), 40 mM KCl, 1% Tween 20, 2 µM oligomycin,
1 mM PMSF, 10 mM KF, 2 mM EGTA, and 1 mM Na vanadate,
as described (Lee et al., 2005). CcO activity was measured in the
presence of 20 mM ascorbate by addition of increasing amounts
of cytochrome c from cow heart (Sigma-Aldrich, St. Louis, MO,
USA). Oxygen consumption was recorded on a computer and
analyzed with the Oxygraph software. Protein concentration was
determined with the DC protein assay kit (Bio-rad, Hercules,
CA, USA). CcO specific activity was defined as consumed O2
(µM)/min/mg total protein.
STATISTICAL ANALYSIS
Separate one-way ANOVAs were performed to compare dif-
ferences between group means for each outcome variable. In
addition, a separate 4 [group: C, CE, (−)−Epi, and (−)−Epi-
Ex] × 3 (time: 0 weeks, 4 weeks, and 8 weeks) mixed factorial
ANOVA was performed for body mass. To determine changes
in exercise capacity, a separate 4 [group: C, CE, (−)−Epi, and
(−)−Epi-Ex] × 2 [time: 0 weeks, and 8 weeks] mixed factorial
ANOVA was performed with total distance ran as the depen-
dent variable. To determine the acute effect of (−)−epicatechin
on the quadriceps muscle of the control group CcO specific
activity was analyzed using a 2 [group: placebo or 20 µM of
(−)−epicatechin] × 10 (cytochrome c concentration: 0, 1, 2, 3,
5, 10, 15, 20, 25, and 30) mixed factorial ANOVA was conducted.
Whenever the overall F-ratio was significant post hoc Tukey’s HSD
was performed. Statistical significance was set at p ≤ 0.05 for all
analyses.
RESULTS
ANIMAL BODY AND MUSCLE MASS
The group× time mixed factorial ANOVA for body mass revealed
a significant interaction [F(6,60) = 2.67; p = 0.023]. The follow-
up analyses revealed no significant differences between groups
(Table 1). There was, however, a significant main effect for time
[F(2,60) = 10.67; p < 0.001]. Therefore, the follow-up analy-
ses indicated that mice were heavier at week 0 (33.0 ± 0.4 g)
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FIGURE 1 | Measurements of capillarity for the plantaris muscle.
(A) (NCAF ): *significantly different than control group (p < 0.0001);
†significantly different than Epi and CE groups (p < 0.0001). (B) (CD):
*significantly different than control group (p ≤ 0.018); †significantly different
than Epi (p = 0.043) and CE (p = 0.005) groups. (C) (C/Fi ): *significantly
different than control group (p < 0.001); †significantly different than Epi and
CE groups (p = 0.001). (D) (CFPE): *significantly different than control
group (p ≤ 0.013); †significantly different than Epi (p = 0.037) and CE
(p = 0.006) groups. (n = 3 per group; mean ± SEM).
compared to weeks 4 (31.9 ± 0.4 g) and 8 (32.4 ± 0.4 g). In
addition, mice in week 4 weighed significantly (p= 0.02) less than
mice in week 8.
The one-way ANOVAs for muscle mass indicated a significant
(p ≤ 0.007) overall F-ratio for the absolute muscle mass for the
plantaris, lateral gastrocnemius, and quadriceps femoris as well
as the relative muscle masses. As shown in Table 1, the follow-up
tests revealed significant mean differences in absolute and relative
muscle masses between the four groups.
ENDURANCE PERFORMANCE
The 4× 2 mixed factorial ANOVA revealed a significant group×
time interaction [F(3,30) = 189.35; p < 0.001] for total distance
ran. We also observed main effects for group [F(3,30) = 168.95;
p < 0.001] and time [F(1,30) = 1266.06; p < 0.001], but due
to the significant interaction these main effects were not inter-
preted (Keppel and Wickens, 2004). Following the significant
interaction, simple main effects test were conducted to deter-
mine mean differences among the four groups. At 8 weeks these
analyses indicated a statistically significant (p < 0.001) increase
in total running distance for the (−)−Epi (226.0 ± 2.8 m),
CE (194.7 ± 2.8 m), and (−)−Epi-Ex (247.0 ± 3.0 m) groups
compared to the control group (134 ± 2.9 m). In addition, we
observed the following statistically significant (p< 0.001) pattern
(−)−Epi-Ex> (−)−Epi>CE for comparisons between the three
experimental groups.
MUSCLE CAPILLARITY
The results of the one-way ANOVAs for the various capillary
indices revealed significant mean differences among the four
Table 2 | Morphometric analyses of the plantaris muscle (mean ±
SEM).
Groups
C (−)−Epi CE (−)−Epi–Ex
Plantaris
muscle
Area
(µm)
2645 ± 125 2375 ± 98 2667 ± 219 2337 ± 98
Perimeter
(µm)
215 ± 14 203 ± 5 221 ± 9 204 ± 7
No significant differences between groups for either index.
groups (Figure 1). Morphometric analyses, however, indicated no
significant differences in mean fiber area and perimeter across the
four groups (Table 2).
PROTEIN EXPRESSION FOR ANGIOGENESIS
The results of the one-way ANOVAs revealed significant mean
differences in protein expression for regulators of angiogen-
esis (Figure 2). VEGF-R2 was significantly increased whereas
ADAMTS1, TSP-1, and FoxO1 were significantly decreased in the
three experimental groups. Moreover, we found no change in
protein levels for TSP-1 receptor, CD47.
PROTEIN EXPRESSION FOR MITOCHONDRIAL PROLIFERATION
As shown in Figure 3, there were significant changes in protein
expression for regulators of mitochondrial biogenesis, PGC-1β
and TFAM, as a result of endurance training, (−)−epicatechin
treatment, or both. Importantly, in the majority of cases, the
group receiving both (−)−epicatechin and endurance training
had higher protein expression for indices of mitochondrial bio-
genesis than the groups receiving (−)−epicatechin or endurance
training.
CITRATE SYNTHASE AND CcO SPECIFIC ACTIVITY
Citrate synthase activity increased significantly in all three groups
compared to the control group (Figure 4A). Moreover, the
(−)−Epi−Ex group had a higher value than the two other exper-
imental groups. In addition, a group × cytochrome c concen-
tration mixed factorial ANOVA revealed a significant interaction
[F(9,63) = 31.85, p < 0.0001] for CcO activity measured in
the quadriceps femoris muscle. As shown in Figure 4B, the
follow-up analyses indicated that for all substrate cytochrome c
concentrations other than zero, there was a significant increase
in mitochondrial respiration in the muscles incubated in 20 µM
(−)−epicatechin for 25 min compared to the vehicle treated
muscle.
DISCUSSION
The main finding of the current study was that mice in the
group that received (−)−epicatechin treatment combined with
8 weeks of endurance training had increases in some regulators
of angiogenesis and mitochondrial biogenesis. This cumulative
effect in signaling resulted in increased capillarity and oxidative
capacity. From a functional perspective, animals in this group
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FIGURE 2 | Basal pro- and anti-angiogenic responses in the
quadriceps femoris muscle following 8 weeks of endurance training
with and without (−)−epicatechin. (A) are representative Western
blots. (B) (VEGF-A) there was no significant difference between groups.
(C) (VEGF-R2): *significantly (p < 0.03) different than control;
**significantly (p = 0.018) different than CE; and †significantly (p = 0.002)
different than CE. (D) (ADAMTS-1): *significantly (p ≤ 0.03) different than
control. (E) (TSP-1): *significantly (p < 0.001) different than control;
††significantly (p < 0.04) different than (−)−Epi and CE groups. (F) (CD47)
there was no different between groups for TSP-1 receptor. (G) (FOXO1):
*significantly (p < 0.04) different than control. (n = 4–5 animals per group;
mean ± SEM).
had the highest exercise tolerance than groups receiving either
(−)−epicatechin treatment or exercise.
SKELETAL MUSCLE CAPILLARITY WITH ENDURANCE TRAINING
AND (−)−EPICATECHIN TREATMENT
Previous studies have examined the role of (−)−epicatechin on
angiogenesis in the brain (van Praag et al., 2007) and skeletal
muscle (Nogueira et al., 2011; Hüttemann et al., 2012, 2013).
For example, (−)−epicatechin treatment and endurance exercise
revealed an increase in cognitive function in mice (van Praag
et al., 2007). Nogueira et al. (2011) reported increased capillarity
with (−)−epicatechin treatment and light exercise in the plantaris
muscle. Both studies, however, did not examine regulators of
angiogenesis (i.e., VEGF-A and TSP-1). Olfert and Birot (2011)
have suggested that capillary development and/or maintenance
may be due to an interaction between pro- and anti-angiogenic
growth factors. Hüttemann et al. (2012, 2013) were the initial
studies to report changes in pro- and anti-angiogenic regulators
with (−)−epicatechin treatment.
In the current investigation we examined the angiogenic
response to (−)−epicatechin treatment in conjunction with
endurance training. We found that compared to the control
group, capillarity increased similarly for groups receiving either
(−)−epicatechin or exercise (range 39–60%). The combination
of (−)−epicatechin treatment with endurance training, however,
increased capillarity (range 74–97%) compared to the control
group. The increase observed in the (−)−Epi-Ex group also
represented an additional increase (range 32–40%) compared to
the (−)−epicatechin or exercise groups. To determine the mech-
anism associated with the increase in capillarity we examined
protein expression of recognized pro- and anti-angiogenic factors
(Figure 2). Although we found that basal VEGF-A expression
did not change in any of the experimental groups there was a
significant increase in its receptor (VEGF-R2). Exercise-induced
increase in VEGF-R2 has been reported previously in young,
healthy mice following 8 weeks of endurance training (Malek
et al., 2013), whereas the lack of increase in basal VEGF-A protein
expression following endurance training is consistent with previ-
ous studies (Malek et al., 2010). Hüttemann et al. (2013) reported
that (−)−epicatechin increased basal VEGF-A protein expression
in the plantaris muscle of rats bred for innate LCR. This may
suggest that the (−)−epicatechin-induced VEGF-A expression
occurs under conditions in which the muscle is compromised
such as severe deconditioning (Hüttemann et al., 2013).
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FIGURE 3 | Basal protein expression of mitochondrial biogenesis
regulators in the quadriceps femoris muscle following 8 weeks of
endurance training with and without (−)−epicatechin. (A) are
representative Western blots. (B) (PGC-1α and PGC-1β): no significant
differences between groups for PGC-1α, whereas for PGC-1β *significantly
(p ≤ 0.014) different than control group; ††significantly (p ≤ 0.02) different
than (−)−Epi and CE groups. (C) (TFAM): *significantly (p < 0.04) different
than control group; and ††significantly (p ≤ 0.015) different than (−)−Epi
and CE groups. (n = 4–5 animals per group; mean ± SEM).
Studies reporting increases in basal VEGF-A protein expres-
sion in the hindlimb muscles have used voluntary wheel run-
ning as their mode of endurance training (Waters et al., 2004;
Zwetsloot et al., 2008; Olenich et al., 2013; Ringholm et al., 2013).
Therefore, the duration of exercise per day for each animal is
significantly higher compared to treadmill exercise. Olenich et
al (Olenich et al., 2013) reported that the average exercise time
mice spent on the running wheel ranged from 205 min (∼3.4 h)
to 363 min (∼6.1 h). Similarly, Allen et al. (Allen et al., 2001)
reported an average of 4.3 h of nightly wheel-running activity in
mice. In the present study the exercise session was 1 h per day
Monday through Friday for a total of 5 h each week. Thus the lack
of an increase in basal VEGF-A protein expression in the current
study may be explained by the relatively low volume of exercise
when using treadmill exercise versus voluntary wheel running.
When anti-angiogenic factors were observed, we found that
basal ADAMTS-1 protein expression significantly decreased in all
three experimental conditions compared to the control group.
Furthermore, we found that basal TSP-1 protein expression was
significantly lower in the (−)−Epi-Ex group compared to the
three other groups (Figure 2). Basal TSP-1 protein expression
in the quadriceps muscle was significantly reduced by either
(−)−epicatechin treatment (48%) or endurance training (38%),
corresponding with a significant increase in capillarity compared
to the control group. The combination of (−)−epicatechin and
endurance training ((−)−Epi-Ex) resulted in an even greater
decrease of basal TSP-1 compared to the (−)−Epi and CE groups
corresponding to higher induction of capillarity (Figure 1). In the
present investigation we did not examine the angiogenic response
in cardiac muscle as the focus was mainly on skeletal muscle. Nev-
FIGURE 4 | Citrate synthase and cytochrome c oxidase activity is
increased in the hindlimb muscles after (−)−epicatechin treatment.
(A) is citrate synthase activity in the lateral gastrocnemius muscle
normalized to the control group *significantly different than control
[p-values ranged from ≤ 0.007 to 0.048; ††different than (−)−Epi and CE,
p < 0.0001; n = 4 animals per group]. (B) is CcO activity which was
determined in the muscle of mice in the control group incubated in the
presence (20 µM final concentration; triangle) or absence (vehicle, circle) of
(−)−epicatechin for 25 min using the polarographic method by increasing
the amount of substrate cytochrome c. CcO activity is defined as
consumed [O2 (µM)/min/protein mg] (*p ≤ 0.001 significantly different from
placebo group, n = 4–5 animals per group, mean ± SEM).
ertheless, previous studies using (−)−epicatechin treatment have
shown increased angiogenesis signaling with (−)−epicatechin
treatment (Nogueira et al., 2011; Ramirez-Sanchez et al., 2012).
Therefore, the increase in exercise tolerance observed in the
(−)−Epi-Ex group may also be, in part, due to potential improve-
ments in cardiac vascularization.
A novel finding in the present study was the effects of
(−)−epicatechin on FoxO1 protein expression either alone or
in combination with endurance training. Recently, Roudier et al.
(2013) reported that FoxO1 regulates TSP-1. In addition, Potente
et al. (Potente et al., 2005) reported that silencing of either
FoxO1 or FoxO3a significantly increased sprout-forming capac-
ity of endothelial cells. Furthermore, Behl et al. (Behl et al.,
2009) showed that inhibition of FoxO1 reduced microvascular
cell loss in the retina of diabetic rats, whereas Kim et al. (2011)
reported that phosphorylation of FoxO1 had an anti-angiogenic
function in gastric carcinoma specimens. Slopack et al. (2014)
found that protein expression of FoxO1 and FoxO3a was sig-
nificantly attenuated after 10 days of endurance training when
compared to sedentary controls. This pattern of response in
skeletal muscle was also observed for TSP-1 protein expression
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(Slopack et al., 2014). In addition, Slopack et al. (2014) found
that endothelial FoxO null mice had a higher capillary-to-fiber
ratio after 7 days of endurance training, whereas this increase
in capillarity was observed after 14 days of training in wildtype
mice. Here, we found that (−)−epicatechin, endurance exercise,
or the combination of both reduced FoxO1 protein expression
in the quadriceps muscle relative to the control group. To our
knowledge, this is the first study to show significant reductions in
FoxO1 with (−)−epicatechin treatment alone or in combination
with endurance training. Future studies, however, are needed to
identify converging pathways between FoxO1 and TSP-1 as it
relates to angiogenesis.
MITOCHONDRIAL SIGNALING WITH ENDURANCE TRAINING
AND (−)−EPICATECHIN TREATMENT
Mitochondria have been called the “powerhouses” of the cell,
because they provide energy to the working muscles during activ-
ities greater than 3 min (Coburn et al., 2012). Furthermore, the
mitochondrion is dynamic and can adapt to external stimuli such
as exercise (Hoppeler and Fluck, 2003). Although studies have
shown that endurance training stimulates mitochondrial biogen-
esis and therefore increased energy production the mechanism
is still under investigation. Some investigators have focused on
the PGC-1 proteins (PGC-1α and PGC-1β) to determine their
role in skeletal muscle mitochondrial biogenesis (Ikeda et al.,
2006; Brault et al., 2010; Rowe et al., 2011; Li et al., 2011;
Derbre et al., 2012). Moreover, it has been hypothesized that
activation of PGC-1α may be responsible for the initial phase
of mitochondrial adaptation to endurance exercise, whereas the
subsequent increase in PGC-1β protein expression facilitates the
maintenance of mitochondrial biogenesis in the working mus-
cle (Wright et al., 2007). The subsequent activation of PGC-1
proteins induces expression of mitochondrial transcription factor
A (TFAM) which regulates mitochondrial DNA gene expression
(Ekstrand et al., 2004).
Although the Nogueira et al. (2011) study did examine TFAM
protein expression in the hindlimb muscles, they did not examine
PGC-1 and FoxO1 protein expressions, or CcO specific activity
following acute exposure to (−)−epicatechin. In the present
study, we examined key components involved in mitochondrial
regulation. To this extent, we found that basal protein expres-
sion of PGC-1α was not significantly different between the four
groups, whereas basal protein expression of PGC-1β was signifi-
cantly different in the three experimental groups compared to the
control group. The groups that received either (−)−epicatechin
or exercise had similar increases after 8 weeks of training, whereas
the combination of (−)−epicatechin treatment with exercise was
associated with a cumulative response (Figure 3). A number
of studies have shown that an increase in PGC-1α expression
corresponds to a decrease in FoxO expression in skeletal muscle
(Sandri et al., 2006; Qin et al., 2010; Chung et al., 2013). For
example, Qin et al. (2010) reported a moderately strong negative
correlation between expression of FoxO1 mRNA and PGC-1α
nuclear protein. Furthermore, the investigators suggested that
PGC-1α expression may repress FoxO1 expression. Similarly,
Sandri et al. (2006) also reported an inverse relationship between
PGC-1α and FoxO3 expression, however, Chung et al. (2013)
used a cell culture model and reported that FoxO6 represses
PGC-1α promoter activity. In the present study, we also found
decreased FoxO1 protein expression across our three experimen-
tal conditions, despite no change in PGC-1α protein expression
from control levels. We did see, however, an increase in PGC-
1β which has been suggested to regulate basal mitochondrial
biogenesis (Meirhaeghe et al., 2003; Liesa et al., 2008). Therefore,
futures studies are needed to examine the patterns of expression
under various perturbations between isoforms of PGC-1 and
FoxO.
We also examined the basal protein expression of TFAM and
citrate synthase activity and found that the (−)−Epi-Ex group
had significantly higher levels than the control group as well
as the two other experimental groups. Moreover, we wanted to
examine the acute effects of (−)−epicatechin treatment on CcO
activity independent of endurance training. That is, we wanted to
determine if acute exposure of skeletal muscle to (−)−epicatechin
would increase CcO activity. Thus, we incubated the quadriceps
femoris muscle from the control group in vitro with or without
(−)−epicatechin for 25 min. As shown in Figure 4B, muscles
incubated with (−)−epicatechin have significantly higher CcO
activity than muscles incubated without (−)−epicatechin. This
observed increase cannot be accounted for by an increase in
protein expression given the short duration and, therefore may
be the result of changes in CcO phosphorylation, which can
have a decisive effect on CcO activity and thus mitochondrial
function (Acin-Perez et al., 2003, 2011; Lee et al., 2005; Prabu
et al., 2006; Samavati et al., 2008). The results of the current study
are consistent with those of Hüttemann et al. (2013) who also
reported that CcO specific activity increased in healthy rat plan-
taris muscle incubated in (−)−epicatechin (20 µM) for 25 min.
Interestingly, when the plantaris muscle from rats with innate
LCR were incubated in (−)−epicatechin there was no increase in
CcO specific activity. This may suggest potential impairment in
signaling pathways controlling the phosphorylation state of CcO.
Future studies, therefore, are needed to elucidate the underlying
mechanism of increased oxygen uptake seen in muscle after a
single 25 min treatment with (−)−epicatechin.
In summary, the results of the present investigation indi-
cate that (−)−epicatechin treatment combined with 8 weeks of
endurance training provide a cumulative effect on a number of
angiogenic and mitochondrial signaling. An interesting finding
was the role of FoxO1 protein expression in both signaling path-
ways. Nevertheless, these changes in the hindlimb muscles were
associated with an enhanced exercise tolerance above and beyond
(−)−epicatechin treatment or exercise alone. Moreover, we found
that acute treatment of skeletal muscle with (−)−epicatechin
significantly increases mitochondrial respiration independent of
exercise. These findings in conjunction with our previous stud-
ies (Nogueira et al., 2011; Hüttemann et al., 2012, 2013) on
(−)−epicatechin suggest a potential therapeutic effect to enhance
capillarity and mitochondrial function either with or without
endurance exercise.
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